Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma. | Cell Mol Gastroenterol Hepatol | 2023 | 37478905 | PubTator, text mining | PubMed |
| Tumor matrix stiffness provides fertile soil for cancer stem cells. | Cancer Cell Int | 2023 | 37468874 | PubTator, text mining | PubMed |
| NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. | PLoS Pathog | 2023 | 37459366 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| Comparative Analysis of Water Extracts from Roselle (Hibiscus sabdariffa L.) Plants and Callus Cells: Constituents, Effects on Human Skin Cells, and Transcriptome Profiles. | Int J Mol Sci | 2023 | 37446030 | PubTator, text mining | PubMed |
| Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae. | Int J Mol Sci | 2023 | 37445873 | PubTator, text mining | PubMed |
| An Emerging Role for Sigma Receptor 1 in Personalized Treatment of Breast Cancer. | Cancers (Basel) | 2023 | 37444574 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| The Effects and Regulatory Mechanism of Casein-Derived Peptide VLPVPQK in Alleviating Insulin Resistance of HepG2 Cells. | Foods | 2023 | 37444365 | PubTator, text mining | PubMed |
| Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma. | Altern Ther Health Med | 2023 | 37442189 | PubTator, text mining | PubMed |
| Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435232 | PubTator, text mining | PubMed |
| Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis B. | Biochem Biophys Res Commun | 2023 | 37419034 | PubTator, text mining | PubMed |
| Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment. | Int J Biol Sci | 2023 | 37416770 | PubTator, text mining | PubMed |
| The intestinal γδ T cells: functions in the gut and in the distant organs. | Front Immunol | 2023 | 37398661 | PubTator, text mining | PubMed |
| Spatial mapping of the DNA adducts in cancer. | DNA Repair (Amst) | 2023 | 37390674 | PubTator, text mining | PubMed |
| Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression. | J Int Med Res | 2023 | 37389562 | PubTator, text mining | PubMed |
| Proteomics of immune cells from liver tumors reveals immunotherapy targets. | Cell Genom | 2023 | 37388918 | PubTator, text mining | PubMed |
| GDF15 promotes weight loss by enhancing energy expenditure in muscle. | Nature | 2023 | 37380764 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp. | Cancers (Basel) | 2023 | 37370809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=12